首页> 外文期刊>Biochemistry and Cell Biology >Attenuation of erythrocyte membrane oxidative stress by Sesbania grandiflora in streptozotocin-induced diabetic rats
【24h】

Attenuation of erythrocyte membrane oxidative stress by Sesbania grandiflora in streptozotocin-induced diabetic rats

机译:大花Se对链脲佐菌素诱导的糖尿病大鼠红细胞膜氧化应激的减轻

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to investigate the protective effects of Sesbania grandiflora flower (SGF) extract on erythrocyte membrane in Streptozotocin (STZ)-induced diabetic rats. Adult male albino rats of Wistar strain, weighing 190-220 g, were made diabetic by an intraperitonial administration of STZ (45 mg/kg). Normal and diabetic rats were treated with SGF, and diabetic rats were also treated with glibenclamide as drug control, for 45 days. In this study plasma insulin and haemoglobin levels were decreased and blood glucose, glycosylated haemoglobin, protein oxidation, lipid peroxidation markers, and osmotic fragility levels were increased in diabetic rats. Moreover, erythrocytes antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxide, glutathione reductase, glutathione-S-transferase, and glucose-6-phosphate dehydrogenase activities and non-enzymatic antioxidants such as vitamin C, vitamin E, reduced glutathione (GSH), and oxidized glutathione (GSSG) levels were altered. Similarly, the activities of total ATPases, Na+/K+-ATPase, Ca2+-ATPase, and Mg2+-ATPase were also decreased in the erythrocytes of diabetic rats. Administration of SGF to STZ-induced diabetic rats reduced blood glucose and glycosylated haemoglobin levels with increased levels of insulin and haemoglobin. Moreover, SGF reversed the protein and lipid peroxidation markers, osmotic fragility, membrane-bound ATPases activities, and antioxidant status in STZ-induced diabetic rats. These results suggest that SGF could provide a protective effect on diabetes by decreasing oxidative stress-associated diabetic complications.
机译:本研究的目的是研究大叶芝麻提取物(SGF)对链脲佐菌素(STZ)诱导的糖尿病大鼠红细胞膜的保护作用。通过腹膜内给予STZ(45mg / kg)使重达190-220g的成年雄性Wistar株的白化病雄性糖尿病。正常和糖尿病大鼠用SGF治疗,糖尿病大鼠也用格列本脲作为药物对照治疗45天。在这项研究中,糖尿病大鼠血浆胰岛素和血红蛋白水平降低,血糖,糖基化血红蛋白,蛋白质氧化,脂质过氧化标志物和渗透脆性水平升高。此外,红细胞抗氧化酶(如超氧化物歧化酶,过氧化氢酶,谷胱甘肽过氧化物,谷胱甘肽还原酶,谷胱甘肽-S-转移酶和葡萄糖-6-磷酸脱氢酶活性)和非酶抗氧化剂(如维生素C,维生素E)可减少谷胱甘肽(GSH) ,并改变了谷胱甘肽(GSSG)的水平。同样,糖尿病大鼠的红细胞中总ATPase,Na + / K + -ATPase,Ca2 + -ATPase和Mg2 + -ATPase的活性也降低。向STZ诱导的糖尿病大鼠中服用SGF可降低血糖和糖基化血红蛋白水平,同时增加胰岛素和血红蛋白的水平。此外,在STZ诱导的糖尿病大鼠中,SGF逆转了蛋白质和脂质过氧化标记,渗透脆性,膜结合ATPase活性以及抗氧化剂状态。这些结果表明,SGF可通过减少氧化应激相关的糖尿病并发症而对糖尿病提供保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号